Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance
- 1 January 2006
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 61 (1), 79-86
- https://doi.org/10.1111/j.1365-2125.2005.02524.x
Abstract
Previous studies have demonstrated that the antihistamines mequitazine, cetirizine and dexchlorpheniramine produce mild sedation after single doses. It is unknown, however, whether acute sedation persists after repeated dosing. Therefore, this study assessed the effects of repeated dosing of these antihistamines on driving and psychomotor performance. Sixteen healthy volunteers were treated with mequitazine 10 mg q.a.m., cetirizine 10 mg q.a.m., dexchlorpheniramine Repetab 6 mg b.i.d. and placebo for four separate 8-day periods. Drug effects were assessed on days 1 and 8 using on-the-road driving tests (highway driving and car following), psychomotor tests (tracking and divided attention) and subjective questionnaires. Dexchlorpheniramine and mequitazine significantly impaired driving performance on the highway driving test on the first day; dexchlorpheniramine increased Standard Deviation of Lateral Position by 2 cm [95% confidence interval (CI) 0.5, 3.8] and mequitazine by 2.5 cm (CI 1.0, 4.3). These effects on driving performance disappeared after 8 days of treatment. No effect of treatment was found on car following, tracking and divided attention. Although subjective ratings confirmed that subjects knew their driving had been impaired in the mequitazine and dexchlorpheniramine condition after completion of the highway driving test on day 1, they did not expect their driving to be affected before the start of the test. Cetirizine did not impair performance on any of the tests. Single doses of mequitazine 10 mg and dexchlorpheniramine Repetab 6 mg cause mild driving impairment. However, when taken over several days, the impairing effect wears off, possibly as a result of tolerance.This publication has 38 references indexed in Scilit:
- Comparative study of acute effects of single doses of fexofenadine, olopatadine,d-chlorpheniramine and placebo on psychomotor function in healthy volunteersHuman Psychopharmacology: Clinical and Experimental, 2003
- Antidepressants and Driver ImpairmentBritish Journal of Psychology, 2003
- The Effects of Single and Repeated Administration of Ebastine on Cognition and Psychomotor Performance in Comparison to Triprolidine and Placebo in Healthy VolunteersCurrent Medical Research and Opinion, 2001
- Functional neuroimaging of cognition impaired by a classical antihistamine, d‐chlorpheniramineBritish Journal of Pharmacology, 2000
- Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performanceJournal of Allergy and Clinical Immunology, 1998
- Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performanceArchives of Internal Medicine, 1997
- Sedative effects of antihistamines: safety, performance, learning, and quality of lifeClinical Therapeutics, 1997
- The clinical safety of H1‐receptor antagonists: An EAACI position paper*Allergy, 1996
- Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989‐94Allergy, 1995
- Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepinessHuman Psychopharmacology: Clinical and Experimental, 1992